Printer Friendly

WATSON PHARMACEUTICALS ANNOUNCES INTENT TO FILE REGISTRATION STATEMENT FOR OFFERING OF COMMON STOCK

 CORONA, Calif., Sept. 24 /PRNewswire/ -- Watson Pharmaceuticals Inc. (NASDAQ: WATS) today announced its intention to file a Registration Statement with the Securities and Exchange Commission covering the offering of approximately 3,000,000 shares of its common stock.
 Of the approximately 3,000,000 shares to be offered, 1,000,000 shares will be offered by the company and up to 2,000,000 shares will be offered on behalf of certain shareholders of the company. The proceeds received by the company from this issue are expected to be used for expansion of its manufacturing facilities, working capital and potential business acquisitions or investments.
 The offering will be made only by means of prospectus.
 Watson is engaged in the manufacture and sale of off-patent medications and the development of advanced drug delivery systems primarily designed to enhance the therapeutic benefits of pharmaceutical compounds.
 -0- 9/24/93
 /CONTACT: Doug Sherk or Stu Brunet, 415-296-7383, or Lisa Carlton or Miriam Adler, 212-850-5600, all of Morgen-Walke, for Watson Pharmaceuticals/
 (WATS)


CO: Watson Pharmaceuticals Inc. ST: California IN: MTC SU: OFR

SG-PK -- SF011 -- 5576 09/24/93 17:01 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 24, 1993
Words:187
Previous Article:T/SF RENEGOTIATES AGREEMENT
Next Article:FEDERAL-MOGUL DECLARES FOURTH-QUARTER DIVIDEND
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters